대한물리의학회지 (Journal of the Korean Society of Physical Medicine)

  • 제18권3호
  • /
  • Pages.21-30
  • /
  • 2023
  • /
  • 1975-311X(pISSN)
  • /
  • 2287-7215(eISSN)
대한물리의학회 (The Korean Society of Physical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Unraveling the Contributing Factors of Sarcopenia in Young Korean Male Adults: A Study of Occurrence, Somatometric, Biochemical, and Behavioral Characteristics

  • 투고 : 2023.07.28
  • 심사 : 2023.08.03
  • 발행 : 2023.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

PURPOSE: The present study evaluated the occurrence, somatometric, biochemical, and behavioral characteristics of young Korean sarcopenic males aged between 30 to 39 years. METHODS: The study involved a total of 1,546 participants. These individuals were divided into two distinct groups based on their skeletal muscle mass index. Of these, 49 participants were categorized into the sarcopenia group, while the remaining 1,497 individuals were placed in the normal group. The researchers analyzed the occurrence of sarcopenia, somatometric, biochemical, and behavioral characteristics such as height, weight, body mass index (BMI), waist circumference (WC), skeletal muscle mass index, fasting glucose (FG), triglyceride and total cholesterol (TC) levels, systolic (SBP) and diastolic blood pressure (DBP), and the drinking and smoking status. A complex sampling data analysis was performed. RESULTS: The weighted occurrence of sarcopenia was found to be 3.24%, (95% confidence interval (CI) of 2.39% to 4.36%). The somatometric contributing factors were height, BMI, and WC (p < .05). Triglyceride and TC levels exhibited statistically significant differences in the biochemical variables (p < .05). The behavioral characteristics, including the drinking and smoking status, had no statistical significance (p > .05). CONCLUSION: This study identified specific occurrences of sarcopenia and contributing factors in young Korean men.

키워드

참고문헌

  1. Population Division, Department of Economic and Social Affairs. United Nations. World population aging. 2019. 4-11.
  2. Wang C, Bai L. Sarcopenia in the elderly: Basic and clinical issues. Geriatr Gerontol Int. 2012;12(3):388-96. https://doi.org/10.1111/j.1447-0594.2012.00851.x
  3. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
  4. Jung HW. Visualizing domains of comprehensive geriatric assessments to grasp frailty spectrum in older adults with a radar chart. Ann Geriatr Med Res. 2020;24(1):55-6. https://doi.org/10.4235/agmr.20.0013
  5. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8. https://doi.org/10.1002/jcsm.12073
  6. Liu X, Hao Q, Yue J, et al. Sarcopenia, obesity and sarcopenia obesity in comparison: Prevalence, metabolic profile, and key differences: Results from WCHAT study. J Nutr Health Aging. 2020;24(4):429-37. https://doi.org/10.1007/s12603-020-1332-5
  7. Hai S, Wang H, Cao L, et al. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17(1):187.
  8. Chan R, Leung J, Woo J. A prospective cohort study to examine the association between dietary patterns and sarcopenia in chinese community-dwelling older people in Hong Kong. J Am Med Dir Assoc. 2016; 17(4):336-42. https://doi.org/10.1016/j.jamda.2015.12.004
  9. Nishiguchi S, Yamada M, Fukutani N, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2015;16(2):120-4. https://doi.org/10.1016/j.jamda.2014.07.010
  10. Kang SY, Lim GE, Kim YK, et al. Association between sarcopenic obesity and metabolic syndrome in postmenopausal women: A cross-sectional study based on the Korean national health and nutritional examination surveys from 2008 to 2011. J Bone Metab. 2017;24(1):9-14. https://doi.org/10.11005/jbm.2017.24.1.9
  11. Velazquez-Alva MC, Irigoyen Camacho ME, Lazarevich I, et al. Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women. Geriatr Gerontol Int. 2017;17(1):161-70. https://doi.org/10.1111/ggi.12652
  12. Lee HN KB. Convergence factors affecting sarcopenia in middle-aged and older women in Korea: A cross sectional study by using 5th KNHANES. J Korean Converg Soc. 2020;11(11):405-16.
  13. Mager D, Carroll M, Wine E, et al. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr. 2018;72(4):623-6. https://doi.org/10.1038/s41430-018-0105-2
  14. Jung HN, Jung CH, Hwang Y-C. Sarcopenia in youth. Metabolism. 2023;144:155557.
  15. Ramsey KA, Rojer AG, D'Andrea L, et al. The association of objectively measured physical activity and sedentary behavior with skeletal muscle strength and muscle power in older adults: A systematic review and meta-analysis. Ageing research reviews. 2021;67:101266.
  16. Maggio M, Lauretani F, Ceda GP. Sex hormones and sarcopenia in older persons. Curr Opin Clin Nutr Metab Care. 2013;16(1):3-13.
  17. Ascenzi F, Barberi L, Dobrowolny G, et al. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell. 2019;18(3):e12954.
  18. Bugge AB. Lovin' it? food. Culture & Society. 2011;14(1):71-89.
  19. Robinson S, Cooper C, Sayer AA. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. Clinical Nutrition and Aging. 2017:3-18.
  20. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693.
  21. Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18-22. https://doi.org/10.1016/j.archger.2016.04.016
  22. Santos VRd, Araujo MYC, Cardoso MR, et al. Association of insufficient physical activity with sarcopenia and sarcopenic obesity in individuals aged 50 years or more. Revista de Nutricao. 2017;30:175-84. https://doi.org/10.1590/1678-98652017000200003
  23. Huschtscha Z, Parr A, Porter J, et al. Sarcopenic characteristics of active older adults: a cross-sectional exploration. Sports Med Open. 2021;7(1):32.
  24. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. Int J Environ Res Public Health. 2022;19(12):7232.
  25. Hwang J, Park S. Sex Differences of sarcopenia in an elderly asian population: the prevalence and risk factors. IInt J Environ Res Public Health. 2022; 19(19):11980.
  26. Hwang J. Prevalence, Anthropometric risk factors, and clinical risk factors in sarcopenic women in their 40s. J Korean Soc Phys Med. 2023;18(2):23-31. https://doi.org/10.3346/jkms.2003.18.1.23
  27. Hwang J. Age-related loss of skeletal muscle and associated risk factors in middle-aged men: a comprehensive study. J Korean Soc Phys Med. 2023;18(2):13-21. https://doi.org/10.13066/kspm.2023.18.2.13
  28. Hwang J, Park S. Gender-specific prevalence and risk factors of sarcopenic obesity in the Korean elderly population: A nationwide cross-sectional study. Int J Environ Res Public Health. 2023;20(2):1140.
  29. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8. https://doi.org/10.1152/jappl.2000.89.1.81
  30. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. https://doi.org/10.1046/j.1532-5415.2002.50216.x
  31. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
  32. World Health O. ICD-10: International statistical classification of diseases and related health problems: tenth revision. (2nd ed ed). Geneva. World Health Organization. 2004.
  33. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58. https://doi.org/10.1093/gerona/glu010
  34. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: The Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69-77. https://doi.org/10.1093/ije/dyt228
  35. Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: Findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902.
  36. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65. https://doi.org/10.1007/s00421-010-1473-z
  37. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa ageing study. Revista De Nutricao-Brazilian J Nutr. 2017;30(3):287-96. https://doi.org/10.1590/1678-98652017000300002
  38. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: A new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95. https://doi.org/10.1016/j.numecd.2007.10.002
  39. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63. https://doi.org/10.1093/ajcn/81.5.953
  40. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-83. https://doi.org/10.1038/nri1937
  41. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005;82(2):428-34. https://doi.org/10.1093/ajcn/82.2.428
  42. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7. https://doi.org/10.1016/j.orcp.2012.02.003
  43. Buchmann N, Nikolov J, Spira D, et al. Identifying sarcopenia in metabolic syndrome: Data from the Berlin aging study II. J Gerontol A Biol Sci Med Sci. 2016;71(2):265-72. https://doi.org/10.1093/gerona/glv089
  44. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109.
  45. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: Mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81. https://doi.org/10.1530/JOE-15-0533
  46. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25. https://doi.org/10.1152/japplphysiol.00627.2006
  47. Therakomen V, Petchlorlian A, Lakananurak N. Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: A cross-sectional study. Sci Rep. 2020;10(1):19551.